|LETTER TO EDITOR
|Year : 2017 | Volume
| Issue : 4 | Page : 554-555
Tramadol-induced hypoglycemia: An unusual adverse effect
Subramanian Senthilkumaran1, Chidambaram Ananth2, Ritesh G Menezes3, Ponniah Thirumalaikolundusubramanian4
1 Department of Emergency and Critical Care, Erode Emergency Care Hospital, Erode, Tamil Nadu, India
2 Department of Anesthesiology, Al-Emadi Hospital, Doha, Qatar
3 Forensic Medicine Division, Department of Pathology, College of Medicine, King Fahd Hospital of the University, University of Dammam, Saudi Arabia
4 Department of Internal Medicine, Chennai Medical College and Research Center, Irungalur, Trichy, Tamil Nadu, India
|Date of Web Publication||9-Jan-2018|
Department of Emergency and Critical Care, Erode Emergency Care Hospital, Veerappampalayam Main Road, Thindal, Erode, Tamil Nadu
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Senthilkumaran S, Ananth C, Menezes RG, Thirumalaikolundusubramanian P. Tramadol-induced hypoglycemia: An unusual adverse effect. J Anaesthesiol Clin Pharmacol 2017;33:554-5
|How to cite this URL:|
Senthilkumaran S, Ananth C, Menezes RG, Thirumalaikolundusubramanian P. Tramadol-induced hypoglycemia: An unusual adverse effect. J Anaesthesiol Clin Pharmacol [serial online] 2017 [cited 2020 Jan 28];33:554-5. Available from: http://www.joacp.org/text.asp?2017/33/4/554/222512
We read the article by Mahmood et al. with great interest, and would like to share our observations of hypoglycemia the following tramadol in our cases of head injury and highlight the probable mechanisms for hypoglycemia induced by tramadol.
We have noticed rapid fall in blood sugar (as low as 50 mg/dl) within 60-90 min after intravenous administration of tramadol in some cases of head injury, who developed features of restlessness and agitation. Similar clinical and biochemical manifestations reappeared when tramadol was administered. Our cases did not suffer from hypoxemia, hypotension, arrhythmias, or any other demonstrable causes to account for restlessness and agitation, and were not on any antidiabetic agents. In our series, hypoglycemia was observed within the first 3-6 days of tramadol treatment in certain group of patients, particularly in elderly and predisposed. Tramadol induces hypoglycemia in some susceptible individuals due to a reduction in hepatic gluconeogenesis  and increased insulin concentration. Apart from that, it enhances insulin signaling which increases hepatic sensitivity to insulin and stimulates glucose utilization by muscles. Even the recent publications , to have described hypoglycemia following tramadol administration. The probable reasons for variations are related to the expression of CYP2D6, and the amount of M1 synthesized for a given dose of tramadol. Approximately, 10% of Italians, Portuguese, and Greeks, and roughly one-third of people from the Arabian peninsula and Eastern Africa are “ultrarapid metabolizers” and susceptible for adverse effects of tramadol when compared to their counterparts.
Tramadol is one of the widely prescribed analgesics by practitioners, as they believe that it is safe. Hence, we have to motivate the practitioners to consider hypoglycemia, whenever their patients on tramadol develop features of restlessness or agitation. Let us teach and train our health science students, and healthcare providers to recognize tramadol-induced hypoglycemia from the point of patient safety.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Mahmood S, Al-Thani H, El-Menyar A, Alani M, Al-Hassani A, Mathrdikkal S, et al.
Tramadol in traumatic brain injury: Should we continue to use it? J Anaesthesiol Clin Pharmacol 2015;31:344-8.
] [Full text]
Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001;50:2815-21.
Yamada J, Sugimoto Y, Kimura I, Takeuchi N, Horisaka K. Serotonin-induced hypoglycemia and increased serum insulin levels in mice. Life Sci 1989;45:1931-6.
Bourne C, Gouraud A, Daveluy A, Grandvuillemin A, Auriche P, Descotes J, et al.
Tramadol and hypoglycaemia: Comparison with other step 2 analgesic drugs. Br J Clin Pharmacol 2013;75:1063-7.
Fournier JP, Azoulay L, Yin H, Montastruc JL, Suissa S. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med 2015;175:186-93.
Nelson LS, Juurlink DN. Tramadol and hypoglycemia: One more thing to worry about. JAMA Intern Med 2015;175:194-5.
Kirchheiner J, Keulen JT, Bauer S, Roots I, Brockmöller J. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J Clin Psychopharmacol 2008;28:78-83.